| 注册
首页|期刊导航|协和医学杂志|优化标准体系,规范临床实践:《医用锗[68Ge]/镓[68Ga]发生器及镓[68Ga]放射性药物质量标准》和《医用镥[177Lu]及其放射性药物的质量标准》解读

优化标准体系,规范临床实践:《医用锗[68Ge]/镓[68Ga]发生器及镓[68Ga]放射性药物质量标准》和《医用镥[177Lu]及其放射性药物的质量标准》解读

赖毓昕 彭雨萌 王国昌

协和医学杂志2025,Vol.16Issue(4):867-873,7.
协和医学杂志2025,Vol.16Issue(4):867-873,7.DOI:10.12290/xhyxzz.2025-0505

优化标准体系,规范临床实践:《医用锗[68Ge]/镓[68Ga]发生器及镓[68Ga]放射性药物质量标准》和《医用镥[177Lu]及其放射性药物的质量标准》解读

Optimizing Standardization Systems and Standardizing Clinical Practice:Interpretation of Quality Standards for Medical 68 Ge/68 Ga Generators and 68 Ga Radiopharmaceuticals and Quality Standards for Medical 177 Lu and Its Radiopharmaceuticals

赖毓昕 1彭雨萌 1王国昌1

作者信息

  • 1. 福建医科大学附属第一医院核医学科,福州 350005||福建医科大学附属第一医院滨海院区国家区域医疗中心核医学科,福州 350212
  • 折叠

摘要

Abstract

On January 1,2022,the China International Association for the Promotion of Science and Technology(CIAPST)officially implemented two pivotal standards:Quality Standards for Medical Germanium-68/Gallium-68(68 Ge/68 Ga)Generators and Gallium-68 Radiopharmaceuticals(T/CI 046-2021)and Quality Standards for Medical Lutetium-177(177 Lu)and Its Radiopharmaceuticals(T/CI 047-2021).These standards introduce innovative requirements for quality control and clinical application of radiopharmaceuticals,marking a significant advancement in China's regulatory framework for nuclear medicine.This article provides a compre-hensive analysis of the technical rationale,QC protocols,and clinical implications outlined in the standards.Against the backdrop of China's evolving nuclear medicine landscape,we further identify challenges in imple-mentation(e.g.,production consistency,regulatory compliance)and propose actionable strategies to optimize radiopharmaceutical quality management systems.Our perspective aims to support the standardization and global integration of China's radiopharmaceutical industry.

关键词

镓-68标记物/镥-177标记物/放射性药物/团体标准

Key words

Gallium-68/Lutetium-177/radiopharmaceuticals/group standard

分类

医药卫生

引用本文复制引用

赖毓昕,彭雨萌,王国昌..优化标准体系,规范临床实践:《医用锗[68Ge]/镓[68Ga]发生器及镓[68Ga]放射性药物质量标准》和《医用镥[177Lu]及其放射性药物的质量标准》解读[J].协和医学杂志,2025,16(4):867-873,7.

基金项目

国家自然科学基金(82402315) (82402315)

福建省自然科学基金(2024J08171) (2024J08171)

福建省科技创新联合资金项目(2023Y9084) (2023Y9084)

福建省级临床重点专科建设项目(2023SZDZK-HYXK) National Natural Science Foundation of China(82402315) (2023SZDZK-HYXK)

Natural Science Foundation of Fujian Province(2024J08171) (2024J08171)

Joint Funds for the Innovation of Science and Technology of Fujian Province(2023Y9084) (2023Y9084)

Fujian Provincial Clinical Key Specialty Construction Project(2023SZDZK-HYXK) (2023SZDZK-HYXK)

协和医学杂志

OA北大核心

1674-9081

访问量3
|
下载量0
段落导航相关论文